Independent Medical & Scientific Consulting

Clinical rigor,
applied where it matters.

Physician consultant (MD, MPH) with 10+ years in pharmaceutical clinical development and medical affairs — supporting trial design, evidence generation, publications, and promotional review with the same standard I held as Director of Medical Governance at Merck.

Start a project View services
ONCOLOGY CARDIOMETABOLIC IMMUNOLOGY WOMEN'S HEALTH
Patients will be randomized 1:1 to receive investigational agent [Agent X] 15 mg once weekly or placebo...
The primary endpoint is change in HbA1c from baseline to Week 52, analyzed using...
Key secondary endpoints include change in body weight and safety safety and tolerability, including adjudicated cardiovascular events.
Adverse events will be graded per CTCAE v5.0 and reviewed by the medical monitor on a rolling basis.
Query — endpoint definition should specify analysis population & missing-data handling before IRB submission.
Approved — claim substantiated by Section 7 reference; consistent with label language.
What I do

Five areas of support, one standard of scientific rigor.

Engagements range from a single protocol review to ongoing evidence generation partnership — scoped to what your team actually needs.

01

Clinical Development & Trial Design

  • Protocol design — scientifically sound, operationally feasible
  • Endpoint selection — aligned with regulatory & scientific standards
  • Protocol review — independent medical/scientific assessment
  • Medical monitoring — ongoing safety & efficacy data review
  • Safety review — benefit-risk assessment
02

Evidence Generation & Strategy

  • Unmet need / gap analysis — where evidence should focus next
  • Literature review — structured synthesis of published data
  • Evidence generation strategy — integrated planning
03

Medical Writing & Publications

  • Manuscripts, abstracts & posters — publication-ready content
  • Synopses — from CSR and source data
04

Promotional & Marketing Support

  • Promotional material review — MLR / PRC support
  • Medical content review — accuracy, balance, compliance
  • Sales rep training — clinical & scientific content
05

Language Services

  • English–French translation — medical & scientific materials
Background

A decade inside global pharma, before consulting from outside it.

I spent 10+ years at Merck and MSD France directing clinical development programs and owning global medical governance — the scientific accuracy and compliance review of medical and clinical materials across US and global markets.

That means when I review a protocol, a manuscript, or a promotional claim, I'm applying the same standard I held internally — not learning the process from the outside.

MD, Obstetrics & Gynecology, and MPH in Epidemiology (ISPED, University of Bordeaux). Fluent in English and French.

2026 — Present
Independent Consulting Medical Director
Medical Affairs, Clinical Development & Medical Writing
2025 — 2026
Clinical Research Director, Global Oncology Development
Merck
2020 — 2025
Director, Global Medical Information
Merck
2018 — 2020
Associate Director, Medical Affairs
Merck
2009 — 2014
Medical Science Liaison & Global Medical Advisor
MSD France — Metabolic Disease